Total pain, opioids, and immune checkpoint inhibitors in the survival of patients with cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Total pain, opioids, and immune checkpoint inhibitors in the survival of patients with cancer

Published:2024-09 Issue:9 Volume:9 Page:103688
ISSN:2059-7029
Container-title:ESMO Open
language:en
Short-container-title:ESMO Open

Author:

Ripamonti C.I.^ORCID,Chelazzi C.^ORCID

Publisher

Elsevier BV

Reference24 articles.

1. Effects of opioids on immune and endocrine function in patients with cancer pain;Bradley;Curr Treat Options Oncol,2023

2. Effect of opioids on survival in patients with cancer;Boland;Cancers (Basel),2022

3. Effect of opioids on cancer survival in patients with chronic pain: a propensity score-matched population-based cohort study;Sun;Br J Anaesth,2022

4. Immune checkpoint inhibitors and opioids in patients with solid tumours: is their association safe? A systematic literature review;Cani;Healthcare (Basel),2022

5. PD-1/PD-L1 checkpoint inhibitors during late stages of life: an ad-hoc analysis from a large multicenter cohort;Santini;J Transl Med,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3